• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

How Colon Cancer Mutates to Escape Immune System

How Colon Cancer Mutates to Escape Immune System

Wnt signaling on a colon cancer tissue (positive staining for nuclear CTNNB1) is inversely correlated with immune infiltration (CD3, CD8, CD45RO, but not FOXP3 staining). Image: Courtesy of Dr. Jonathan Nowak

A UCLA-led study has found how colon cancer alters its genes during development to avoid detection by the immune system, creating a specific genetic imprint in the process. This ability of cancer to change its genes — a process called immunoediting — had never been described in colon cancer before; the new understanding could help researchers to develop new immunotherapies that target those genetic changes.

“By identifying the evolution of changes needed to escape the immune system, researchers should be able to design treatments that empower the immune system to outsmart the cancer,” says Catherine Grasso, PhD, assistant professor of medicine at the David Geffen School of Medicine at UCLA. “We expect that in the future, we’ll be testing new immunotherapies to prevent the development of colon cancer, while also using combinations of different agents to treat advanced cancers.”

Investigators from UCLA’s Jonsson Comprehensive Cancer Center, the Broad Institute, the Parker Institute for Cancer Immunotherapy and the Fred Hutchinson Cancer Institute used the genetic analyses of more than 1,200 colon cancers from the Cancer Genome Atlas, the Nurses’ Health Study and the Health Professionals Follow-up Study. Because the cancers were sequenced at the DNA and RNA levels, researchers were able to make highly detailed assessments of the changes that were made to evade the immune system.

Among their findings was that more mutated cancers, called MSI-high (for high microsatellite instability), have more alterations of genes that interact with the immune system. That is significant because the 15 percent of colon cancers in this category currently can be treated with a type of immunotherapy that acts on a specific receptor, known as PD-1, located on cells in the immune system. This receptor normally functions as a brake to the immune system.

Immunotherapy releases this brake, allowing the immune system to attack cancer cells when it recognizes their high frequency of mutations as abnormal. Knowing how cancer cells change could help scientists further refine immunotherapy treatments for such cancers.

The study also shed light on the 85 percent of colon cancers that are not MSI-high. These cancers have fewer mutations and are not usually attacked by the immune system; instead, they have alterations in Wnt signaling, a pathway important in cell development. The study documents the extent to which Wnt-activating mutations were associated with the lack of an immune response in the tumor.

“The genetic data show that colon cancer is being attacked by the immune system from the start, even before immunotherapies based on an immune-checkpoint blockade have been given to patients,” says Antoni Ribas, MD (FEL ’98, ’01), director of the cancer center’s Tumor Immunology Program.

Researchers also showed that as Wnt signaling increases, immune infiltration in colon cancer decreases. This suggested that inhibitors of Wnt signaling could potentially stimulate immune infiltration so that the tumors could respond to immunotherapy. 

“Genetic Mechanisms of Immune Evasion in Colorectal Cancer,” Cancer Discovery, March 6, 2018.


Previous
After Two Years in Darkness and Pain, a Young Woman Sees Again
Next
Men at Risk for Breast Cancer but Often Forego Genetic Tests


YOU ARE VIEWING

Fall 2018

Fall 2018
Printable PDF
IN THIS ISSUE
  • A Decade of Care and Discovery
  • After Two Years in Darkness and Pain, a Young Woman Sees Again
  • How Colon Cancer Mutates to Escape Immune System
  • Men at Risk for Breast Cancer but Often Forego Genetic Tests
  • Good Cholesterol Compound Inhibits Growth of Lung Tumors
  • Public Mental Health Care for Older Californians Lags as Need Grows
  • Gel Material May Help to Regrow Brain Tissue Following Stroke
  • Present at the Creation
  • Reach for the Stars
  • Dr. Plath’s Pluripotent-ial
  • The Pluripotent-ialist: Expanded Interview with Dr. Kathrin Plath
  • How Immunotherapy Became the Next Big Thing
  • The Prize
  • Invisible Pain
  • Virtual Traveler
  • Awards & Honors
  • Return of the Class of ’98
  • Focusing on Whole Health at The Wonder of Women Summit
  • UCLA Medical Center Boards Pass the Gavel
  • Taste for a Cure Raises Money for Cancer Research
  • Using Metabolism to Drive Breakthroughs in Cancer Research
  • Giving Back to Change Lives
  • UCLA Semel Institute Introduces the New Max Gray Fellows in Mood Disorders
  • UCLA Takes on Depression
  • Music and Philanthropy Advance Autism Care
  • Building Connections between Art and Neuroscience at Hammer Museum
  • Tour de Pier Continues to Exceed its Fundraising Goals
  • Bringing Awareness to Food Allergies
  • A Breath of Lung Health
  • Altering the Course of Cardiovascular Research at UCLA
  • Gifts
  • In Memoriam
  • A Blessed Man
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth